Centogene NV
NASDAQ:CNTG
Centogene NV
Interest Income Expense
Centogene NV
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Centogene NV
NASDAQ:CNTG
|
Interest Income Expense
-€4.8m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Interest Income Expense
€313.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
121%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Interest Income Expense
€42.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
134%
|
CAGR 10-Years
47%
|
|
Immatics NV
NASDAQ:IMTX
|
Interest Income Expense
€4.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Interest Income Expense
-€35.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-19%
|
|
Formycon AG
XETRA:FYB
|
Interest Income Expense
€14.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Centogene NV's Interest Income Expense?
Interest Income Expense
-4.8m
EUR
Based on the financial report for Dec 31, 2022, Centogene NV's Interest Income Expense amounts to -4.8m EUR.
What is Centogene NV's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-39%
Over the last year, the Interest Income Expense growth was -435%. The average annual Interest Income Expense growth rates for Centogene NV have been -36% over the past three years , -39% over the past five years .